ARROS-1 Trial of Zidesamtinib Aims to Address Current TKI Li

ARROS-1 Trial of Zidesamtinib Aims to Address Current TKI Limitations in ROS1+ NSCLC

ARROS-1 Trial of Zidesamtinib Aims to Address Current TKI Limitations in ROS1+ NSCLC

onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Washington , Australia , Georgetown University , District Of Columbia , America , American , Stephenv Liu , Crizotinib Xalkori , European Organisation For Research , Nuvalent Inc , National Cancer Institute , American Association For Cancer Research Symposium , Georgetown Lombardi Comprehensive Cancer Center , Demonstrates Early Phase Efficacy , European Organisation , American Association , Cancer Research , North America , Heart Therapeutics ,